Amplia Therapeutics(INNMF)
$0.06+0.01 (+10.53%)
INNMF
Amplia Therapeutics financials statements
$0.06
At close:+0.01 (+10.53%)
Amplia Therapeutics (INNMF) Ratios
19 Followers
Amplia Therapeutics Ratios
INNMF's free cash flow for Q4 2026 was AU$-1.09M. For the 2026 fiscal year, INNMF's free cash flow was decreased by AU$-7.30K and operating cash flow was AU$-1.09M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 19.78 | 7.91 | 1.98 | 3.82 | 31.18 |
| Quick Ratio | 19.78 | 7.91 | 1.98 | 3.82 | 31.18 |
| Cash Ratio | 16.67 | 5.75 | 0.99 | 3.37 | 27.55 |
| Solvency Ratio | -3.87 | -3.43 | -1.29 | -2.17 | -1.38 |
| Operating Cash Flow Ratio | -5.23 | -3.65 | -1.51 | -1.92 | -8.30 |
| Short-Term Operating Cash Flow Coverage | -97.85 | 0.00 | -3.44 | -2.51 | 0.00 |
| Net Current Asset Value | AU$ 31.07M | AU$ 13.02M | AU$ 3.33M | AU$ 7.66M | AU$ 13.90M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.11 | 0.12 | 0.09 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.14 | 0.14 | 0.10 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.12 | 0.13 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Financial Leverage Ratio | 1.05 | 1.09 | 1.30 | 1.18 | 1.12 |
| Debt Service Coverage Ratio | -77.94 | -53.87 | -0.03 | -2.83 | -1441.01 |
| Interest Coverage Ratio | -758.70 | -116.60 | -56.38 | -138.82 | -3167.88 |
| Debt to Market Cap | 0.00 | 0.00 | 0.10 | 0.13 | 0.10 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | 2.10 | 1.60 | 0.40 | 0.96 | 3.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 94.43% | 90.07% | 93.83% | 99.84% |
| EBIT Margin | 0.00% | -179.51% | -102.64% | -616.82% | -183.72% |
| EBITDA Margin | 0.00% | -179.24% | -100.70% | -610.65% | -183.55% |
| Operating Profit Margin | 0.00% | -172.22% | -99.38% | -628.45% | -183.69% |
| Pretax Profit Margin | 0.00% | -173.69% | -200.80% | -621.35% | -183.74% |
| Net Profit Margin | 0.00% | -173.69% | -101.14% | -524.80% | -183.74% |
| Continuous Operations Profit Margin | 0.00% | -74.01% | -101.14% | -524.80% | -183.74% |
| Net Income Per EBT | 61.73% | 100.00% | 50.37% | 84.46% | 100.00% |
| EBT Per EBIT | 94.73% | 100.86% | 202.06% | 98.87% | 100.03% |
| Return on Assets (ROA) | -18.60% | -28.65% | -30.34% | -33.41% | -14.88% |
| Return on Equity (ROE) | -19.53% | -31.26% | -39.44% | -39.42% | -16.68% |
| Return on Capital Employed (ROCE) | -33.14% | -30.96% | -38.67% | -46.91% | -15.21% |
| Return on Invested Capital (ROIC) | -20.41% | -13.18% | -17.13% | -34.85% | -6.93% |
| Return on Tangible Assets | -23.00% | -43.82% | -65.20% | -58.09% | -22.03% |
| Earnings Yield | -6.98% | -30.57% | -31.02% | -37.86% | -17.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 1.00 | 1.40 | 1.04 | 1.08 |
| Payables Turnover | 0.07 | 0.13 | 0.28 | 0.21 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 217.91 | 44.12 | 6.44 | 153.57 |
| Asset Turnover | 0.00 | 0.16 | 0.30 | 0.06 | 0.08 |
| Working Capital Turnover Ratio | 0.00 | 0.46 | 0.80 | 0.10 | 0.22 |
| Cash Conversion Cycle | -5547.22 | -2347.44 | -1063.63 | -1375.32 | -41619.78 |
| Days of Sales Outstanding | 0.00 | 363.84 | 260.48 | 352.40 | 339.18 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 5547.22 | 2711.29 | 1324.12 | 1727.72 | 41958.96 |
| Operating Cycle | 0.00 | 363.84 | 260.48 | 352.40 | 339.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -262.22 | -3323.32 | -2303.32 | -300.02 | -305.65 |
| Capital Expenditure Coverage Ratio | -262.22 | -3323.32 | -2303.32 | -300.02 | -305.65 |
| Operating Cash Flow Coverage Ratio | -25.60 | -495.64 | -3.23 | -2.33 | -2.10 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.82 | -1.15 | -4.45 | -2.22 |
| Free Cash Flow Yield | -7.94% | -32.04% | -35.33% | -32.19% | -21.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.33 | -3.27 | -3.22 | -2.64 | -5.63 |
| Price-to-Sales (P/S) Ratio | 0.00 | 5.68 | 3.26 | 13.86 | 10.34 |
| Price-to-Book (P/B) Ratio | 2.80 | 1.02 | 1.27 | 1.04 | 0.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -12.59 | -3.12 | -2.83 | -3.11 | -4.64 |
| Price-to-Operating Cash Flow Ratio | -12.64 | -3.12 | -2.83 | -3.12 | -4.66 |
| Price-to-Earnings Growth (PEG) Ratio | 0.61 | 0.42 | 0.12 | -0.09 | -1.12 |
| Enterprise Value Multiple | -6.33 | -1.57 | -2.84 | -1.31 | -2.20 |
| Enterprise Value | 82.85M | 10.65M | 12.72M | 9.50M | 8.00M |
| EV to EBITDA | -6.33 | -1.57 | -2.84 | -1.31 | -2.20 |
| EV to Sales | 0.00 | 2.81 | 2.86 | 7.99 | 4.04 |
| EV to Free Cash Flow | -9.45 | -1.55 | -2.48 | -1.79 | -1.81 |
| EV to Operating Cash Flow | -9.49 | -1.55 | -2.48 | -1.80 | -1.82 |
| Tangible Book Value Per Share | 0.07 | 0.04 | 0.02 | 0.04 | 0.10 |
| Shareholders’ Equity Per Share | 0.08 | 0.07 | 0.06 | 0.08 | 0.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.38 | 0.57 | 0.50 | 0.16 | 0.54 |
| Revenue Per Share | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 |
| Net Income Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Tax Burden | 0.62 | 1.00 | 0.50 | 0.84 | 1.00 |
| Interest Burden | 0.95 | 0.97 | 1.96 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.99 | 1.30 | 3.94 | 1.90 |
| SG&A to Revenue | 0.00 | 0.73 | 0.58 | 1.85 | 0.82 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.00 | 0.18 | 0.03 |
| Income Quality | 1.13 | 1.05 | 1.14 | 0.85 | 1.21 |
Currency in AUD
